Selected research
Industry Research
Gene Sequencing Industry Research Report 2026
Market perspective
The global Gene Sequencing market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Gene Sequencing market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Gene Sequencing market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Gene Sequencing market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Gene Sequencing include Illumina, Thermo Fisher Scientific, Eurofins Scientific, BGI Genomics, Natera, Berry Genomics, Roche, Novogene and Mgi Tech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Gene Sequencing market in terms of revenue (US$ million) and, where applicable, service volume (Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Gene Sequencing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Gene Sequencing Market by Company
Illumina
Thermo Fisher Scientific
Eurofins Scientific
BGI Genomics
Natera
Berry Genomics
Roche
Novogene
Mgi Tech
LabCorp
Pacific Biosciences
Azenta Life Sciences
Oxford Nanopore
Macrogen
Gene Sequencing Segment by Type
Next-generation Sequencing
Third and Fourth Generation Sequencing
First-generation Sequencing
Gene Sequencing Segment by Application
Academic Research
Clinical Research
Hospital Clinic
Pharmaceuticals and Biotechnology
Others
Gene Sequencing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Gene Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Sequencing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Gene Sequencing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Next-generation Sequencing
- Third and Fourth Generation Sequencing
- First-generation Sequencing
Applications
- Academic Research
- Clinical Research
- Hospital Clinic
- Pharmaceuticals and Biotechnology
- Others
Companies covered
- Illumina
- Thermo Fisher Scientific
- Eurofins Scientific
- BGI Genomics
- Natera
- Berry Genomics
- Roche
- Novogene
- Mgi Tech
- LabCorp
- Pacific Biosciences
- Azenta Life Sciences
- Oxford Nanopore
- Macrogen
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Gene Sequencing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Next-generation Sequencing
- 2.2.3 Third and Fourth Generation Sequencing
- 2.2.4 First-generation Sequencing
- 2.3 Gene Sequencing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academic Research
- 2.3.3 Clinical Research
- 2.3.4 Hospital Clinic
- 2.3.5 Pharmaceuticals and Biotechnology
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Gene Sequencing Breakdown Data by Type
- 3.1 Global Gene Sequencing Historic Market Size by Type (2021-2026)
- 3.2 Global Gene Sequencing Forecasted Market Size by Type (2027-2032)
4 Gene Sequencing Breakdown Data by Application
- 4.1 Global Gene Sequencing Historic Market Size by Application (2021-2026)
- 4.2 Global Gene Sequencing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Gene Sequencing Market Perspective (2021-2032)
- 5.2 Global Gene Sequencing Growth Trends by Region
- 5.2.1 Global Gene Sequencing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Gene Sequencing Historic Market Size by Region (2021-2026)
- 5.2.3 Gene Sequencing Forecasted Market Size by Region (2027-2032)
- 5.3 Gene Sequencing Market Dynamics
- 5.3.1 Gene Sequencing Industry Trends
- 5.3.2 Gene Sequencing Market Drivers
- 5.3.3 Gene Sequencing Market Challenges
- 5.3.4 Gene Sequencing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Gene Sequencing Players by Revenue
- 6.1.1 Global Top Gene Sequencing Players by Revenue (2021-2026)
- 6.1.2 Global Gene Sequencing Revenue Market Share by Players (2021-2026)
- 6.2 Global Gene Sequencing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Gene Sequencing Head Office and Area Served
- 6.4 Global Gene Sequencing Players, Product Type & Application
- 6.5 Global Gene Sequencing Manufacturers Established Date
- 6.6 Global Gene Sequencing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Gene Sequencing Market Size (2021-2032)
- 7.2 North America Gene Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Gene Sequencing Market Size by Country (2021-2026)
- 7.4 North America Gene Sequencing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Gene Sequencing Market Size (2021-2032)
- 8.2 Europe Gene Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Gene Sequencing Market Size by Country (2021-2026)
- 8.4 Europe Gene Sequencing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Gene Sequencing Market Size (2021-2032)
- 9.2 Asia-Pacific Gene Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Gene Sequencing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Gene Sequencing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Gene Sequencing Market Size (2021-2032)
- 10.2 South America Gene Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Gene Sequencing Market Size by Country (2021-2026)
- 10.4 South America Gene Sequencing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Gene Sequencing Market Size (2021-2032)
- 11.2 Middle East & Africa Gene Sequencing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Gene Sequencing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Gene Sequencing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina
- 12.1.1 Illumina Company Information
- 12.1.2 Illumina Business Overview
- 12.1.3 Illumina Revenue in Gene Sequencing Business (2021-2026)
- 12.1.4 Illumina Gene Sequencing Product Portfolio
- 12.1.5 Illumina Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Gene Sequencing Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Gene Sequencing Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Eurofins Scientific
- 12.3.1 Eurofins Scientific Company Information
- 12.3.2 Eurofins Scientific Business Overview
- 12.3.3 Eurofins Scientific Revenue in Gene Sequencing Business (2021-2026)
- 12.3.4 Eurofins Scientific Gene Sequencing Product Portfolio
- 12.3.5 Eurofins Scientific Recent Developments
- 12.4 BGI Genomics
- 12.4.1 BGI Genomics Company Information
- 12.4.2 BGI Genomics Business Overview
- 12.4.3 BGI Genomics Revenue in Gene Sequencing Business (2021-2026)
- 12.4.4 BGI Genomics Gene Sequencing Product Portfolio
- 12.4.5 BGI Genomics Recent Developments
- 12.5 Natera
- 12.5.1 Natera Company Information
- 12.5.2 Natera Business Overview
- 12.5.3 Natera Revenue in Gene Sequencing Business (2021-2026)
- 12.5.4 Natera Gene Sequencing Product Portfolio
- 12.5.5 Natera Recent Developments
- 12.6 Berry Genomics
- 12.6.1 Berry Genomics Company Information
- 12.6.2 Berry Genomics Business Overview
- 12.6.3 Berry Genomics Revenue in Gene Sequencing Business (2021-2026)
- 12.6.4 Berry Genomics Gene Sequencing Product Portfolio
- 12.6.5 Berry Genomics Recent Developments
- 12.7 Roche
- 12.7.1 Roche Company Information
- 12.7.2 Roche Business Overview
- 12.7.3 Roche Revenue in Gene Sequencing Business (2021-2026)
- 12.7.4 Roche Gene Sequencing Product Portfolio
- 12.7.5 Roche Recent Developments
- 12.8 Novogene
- 12.8.1 Novogene Company Information
- 12.8.2 Novogene Business Overview
- 12.8.3 Novogene Revenue in Gene Sequencing Business (2021-2026)
- 12.8.4 Novogene Gene Sequencing Product Portfolio
- 12.8.5 Novogene Recent Developments
- 12.9 Mgi Tech
- 12.9.1 Mgi Tech Company Information
- 12.9.2 Mgi Tech Business Overview
- 12.9.3 Mgi Tech Revenue in Gene Sequencing Business (2021-2026)
- 12.9.4 Mgi Tech Gene Sequencing Product Portfolio
- 12.9.5 Mgi Tech Recent Developments
- 12.10 LabCorp
- 12.10.1 LabCorp Company Information
- 12.10.2 LabCorp Business Overview
- 12.10.3 LabCorp Revenue in Gene Sequencing Business (2021-2026)
- 12.10.4 LabCorp Gene Sequencing Product Portfolio
- 12.10.5 LabCorp Recent Developments
- 12.11 Pacific Biosciences
- 12.11.1 Pacific Biosciences Company Information
- 12.11.2 Pacific Biosciences Business Overview
- 12.11.3 Pacific Biosciences Revenue in Gene Sequencing Business (2021-2026)
- 12.11.4 Pacific Biosciences Gene Sequencing Product Portfolio
- 12.11.5 Pacific Biosciences Recent Developments
- 12.12 Azenta Life Sciences
- 12.12.1 Azenta Life Sciences Company Information
- 12.12.2 Azenta Life Sciences Business Overview
- 12.12.3 Azenta Life Sciences Revenue in Gene Sequencing Business (2021-2026)
- 12.12.4 Azenta Life Sciences Gene Sequencing Product Portfolio
- 12.12.5 Azenta Life Sciences Recent Developments
- 12.13 Oxford Nanopore
- 12.13.1 Oxford Nanopore Company Information
- 12.13.2 Oxford Nanopore Business Overview
- 12.13.3 Oxford Nanopore Revenue in Gene Sequencing Business (2021-2026)
- 12.13.4 Oxford Nanopore Gene Sequencing Product Portfolio
- 12.13.5 Oxford Nanopore Recent Developments
- 12.14 Macrogen
- 12.14.1 Macrogen Company Information
- 12.14.2 Macrogen Business Overview
- 12.14.3 Macrogen Revenue in Gene Sequencing Business (2021-2026)
- 12.14.4 Macrogen Gene Sequencing Product Portfolio
- 12.14.5 Macrogen Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst